Skip to main content

Table 1 In vitro selectivity of DPP-4 inhibitors (fold selectivity for DPP-4 versus other enzymes) (Adapted from Gupta et al.)[8]

From: Linagliptin: farmacology, efficacy and safety in type 2 diabetes treatment

Idpp4

FAPα

DPP-8

DPP-9

Vildagliptin

285

270

32

Saxagliptin

?

390

77

Sitagliptin

>5.500

>2.660

>5.550

Alogliptin

>14.000

>14.000

>14.000

Linagliptin

89

40.000

>10.000

  1. FAP α Fibroblast activation protein α, DPP-8 Dipeptidyl peptidase-8, DPP-9 Dipeptidyl peptidase-9.